Sartar Therapeutics

📍 Helsinki, Finland🗓 Founded 2016👥 9 employees💰 Last funded 2026
Pharmaceutical Manufacturing🌐 sartartherapeutics.com
Website LinkedIn
Sartar Therapeutics develops treatment for soft tissue sarcomas. The focus of cancer therapy is moving towards personalised medicine. There is a clear unmet need to find new therapies for the broad and heterogeneous group of soft tissue sarcomas. We are committed to delivering innovative, therapeutic options for the patients who currently have no specific therapies and for those who have run out of all currently available options.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Finland
1
Frequently asked questions
Who invested in Sartar Therapeutics?
Sartar Therapeutics has 1 investors on record on gritt.io and 1 late-stage investors.
When did Sartar Therapeutics last raise funding?
The most recent investment in Sartar Therapeutics recorded on gritt.io was in 2026.
When was Sartar Therapeutics founded?
Sartar Therapeutics was founded in 2016.
What industry is Sartar Therapeutics in?
Sartar Therapeutics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Sartar Therapeutics based?
Sartar Therapeutics is headquartered in Helsinki, Finland.